Benzinga's Top Upgrades, Downgrades For August 16, 2018

Top Upgrades

  • Argus upgraded Lululemon Athletica inc. LULU from Hold to Buy. Lululemon shares rose 1.02 percent to $127.74 in pre-market trading.
  • Morgan Stanley upgraded Embraer SA (ADR) ERJ from Equal-Weight to Overweight. Embraer shares fell 2.51 percent to close at $18.65 on Wednesday.
  • Analysts at Compass Point upgraded GreenSky Inc GSKY from Neutral to Buy. GreenSky shares fell 1.83 percent to $15.62 in pre-market trading.
  • Canaccord Genuity upgraded Canopy Growth Corp CGC from Hold to Speculative Buy. Canopy Growth shares rose 2.93 percent to $33.05 in pre-market trading.
  • Jefferies upgraded TechnipFMC PLC FTI from Hold to Buy. TechnipFMC shares rose 1.27 percent to $27.95 in pre-market trading.
  • Goldman Sachs upgraded Avalara Inc AVLR from Neutral to Buy. Avalara shares rose 6 percent to $36.75 in pre-market trading.
  • JP Morgan upgraded Kimberly Clark Corp KMB from Underweight to Neutral. Kimberly-Clark shares rose 0.46 percent to $116.99 in pre-market trading.

 

Top Downgrades

  • Macquarie downgraded Himax Technologies, Inc. (ADR) HIMX from Outperform to Neutral. Himax shares fell 8 percent to close at $5.98 on Wednesday.
  • Morgan Stanley downgraded Healthcare Trust Of America Inc HTA from Overweight to Equal-Weight. Healthcare Trust shares fell 0.48 percent to $28.82 in pre-market trading.
  • DA Davidson downgraded Nanometrics Incorporated NANO from Buy to Neutral. Nanometrics shares fell 2.39 percent to $44.14 in pre-market trading.
  • HSBC downgraded Cemex SAB de CV (ADR) ADR CX from Buy to Hold. Cemex shares fell 3.82 percent to close at $6.79 on Wednesday.
  • Canaccord Genuity downgraded Cenovus Energy Inc CVE from Buy to Hold. Cenovus Energy shares rose 1.67 percent to $9.10 in pre-market trading.
  • Jefferies downgraded AstraZeneca plc (ADR) AZN from Buy to Hold. AstraZeneca shares fell 0.34 percent to $38.32 in pre-market trading.
  • Barclays downgraded Grupo Aeroportuario del Centro Nort(ADR) OMAB from Overweight to Equal-Weight. Grupo Aeroportuario del Centro Nort(ADR) shares fell 3.04 percent to close at $49.40 on Wednesday.
  • KeyBanc downgraded Multi-Color Corporation LABL from Sector Weight to Underweight. Multi-Color shares fell 0.01 percent to $63.84 in pre-market trading.
  • Bank of America downgraded Coty Inc COTY from Buy to Underperform. Coty shares fell 2.19 percent to $11.18 in pre-market trading.

 

Top Initiations

  • UBS initiated Lockheed Martin Corporation LMT with a Buy rating. The price target for Lockheed Martin is set to $400. Lockheed Martin shares closed at $317.70 on Wednesday.
  • Leerink Swann initiated coverage on Teladoc Health Inc TDOC with an Outperform rating. The price target for Teladoc Health is set to $90. Teladoc Health shares closed at $70.75 on Wednesday.
  • Analysts at H.C. Wainwright initiated coverage on AVEO Pharmaceuticals, Inc. AVEO with a Buy rating. The price target for AVEO Pharmaceuticals is set to $6.50. AVEO Pharmaceuticals shares closed at $2.18 on Wednesday.
  • Analysts at UBS initiated coverage on Northrop Grumman Corporation NOC with a Neutral rating. The price target for Northrop Grumman is set to $315. Northrop Grumman shares closed at $291.51 on Wednesday.
  • Piper Jaffray initiated coverage on Post Holdings Inc POST with an Overweight rating. The price target for Post Holdings is set to $115. Post Holdings closed at $94.78 on Wednesday.
  • BTIG Research initiated coverage on Stryker Corporation SYK with a Buy rating. The price target for Stryker is set to $187. Stryker shares closed at $166.78 on Wednesday.
  • Jefferies initiated coverage on Conn's Inc CONN with a Buy rating. The price target for Conn's is set to $44. Conn's shares closed at $33.85 on Wednesday.
  • Analysts at Chardan Capital initiated coverage on eHealth, Inc. EHTH with a Buy rating. The price target for eHealth is set to $40. eHealth closed at $29.04 on Wednesday.
  • Ladenburg Thalmann initiated coverage on AcelRx Pharmaceuticals Inc ACRX with a Buy rating. The price target for AcelRx Pharmaceuticals is set to $7. AcelRx Pharmaceuticals shares closed at $2.95 on Wednesday.
  • Analysts at UBS initiated coverage on Hexcel Corporation HXL with a Sell rating. The price target for Hexcel is set to $65. Hexcel closed at $68.42 on Wednesday.

Posted In: Aerospace & DefenseApparel, Accessories & Luxury GoodsConsumer DiscretionaryIndustrialsInformation TechnologyInitiationsSemiconductor Equipmenttop upgradesUpgradesDowngradesInitiationPre-Market OutlookAnalyst Ratings

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.